Question 1

What is Sotalol?

Accepted Answer

Sotalol is a medication that helps regulate the heart's electrical activity to maintain a steady rhythm. It functions by combining the properties of beta-blockers with actions that stabilize the heart's electrical signals.

By affecting how the heart responds to certain nerve impulses, the medication helps the heart muscle beat more regularly and efficiently. This action is intended to manage irregular heart rhythms that can interfere with normal heart function.

Question 2

What is Sotalol used for?

Accepted Answer

Sotalol is used to treat life-threatening ventricular arrhythmias , as well as for the maintenance of sinus rhythm in symptomatic atrial fibrillation or atrial flutter .

Question 3

How does Sotalol work?

Accepted Answer

How Sotalol Works

Sotalol belongs to a group of medicines known as antiarrhythmics. It works by affecting the response to some nerve impulses in certain parts of the body, particularly the heart. It has two main ways of helping the heart beat more regularly:

Beta-blocking action: Sotalol blocks the effects of certain natural chemicals, like adrenaline, on the heart. This helps slow down the heart rate and reduces the force with which the heart muscle contracts.

Electrical stabilization: The medication also affects the electrical signals that control the heartbeat. By blocking potassium channels in the heart cells, it increases the time the heart stays in a resting state between beats. This helps prevent the heart from beating too fast or in an irregular pattern.

Together, these actions help the heart maintain a normal rhythm and improve its overall efficiency in pumping blood throughout the body.

Question 4

What are the brand names for Sotalol?

Accepted Answer

Sotalol is sold under the brand names Betapace , Sotylize , and Sorine .

Question 5

What are the active ingredients in Sotalol?

Accepted Answer

The active ingredient in Sotalol is sotalol .

Question 6

What are the side effects of Sotalol?

Accepted Answer

Common side effects of Sotalol may include:

Fatigue

Dizziness

Slow heart rate

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Sotalol?

Accepted Answer

Sotalol belongs to the beta blocker and antiarrhythmic drug class.

Question 8

What is the dosage of Sotalol and how do I take it?

Accepted Answer

How to Take Sotalol

Sotalol is most commonly taken by mouth in tablet or liquid form. It may also be administered as an injection or infusion by a healthcare professional in a hospital setting. When taking the oral form, it is important to follow the specific schedule provided by your doctor, as different versions of sotalol are used for different heart conditions and are not always interchangeable.

Take this medication at the same times every day to maintain a steady level in your body.

If you are using the oral liquid form, use a marked measuring device to ensure the correct amount is taken.

Do not stop taking this medication suddenly without consulting your healthcare provider.

Missed Dose

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and return to your regular dosing schedule. Do not take two doses at once to make up for a missed one.

Question 9

Is Sotalol safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

There are no adequate and well-controlled studies regarding the use of sotalol in pregnant women. Research indicates that sotalol crosses the placenta and is found in amniotic fluid. While animal studies at high doses did not show a high risk of birth defects, they did show an increased risk of pregnancy loss.

Beta-blockers like sotalol may reduce blood flow to the placenta, which can lead to complications such as:

Slowed fetal growth

Premature delivery

Fetal death

Infants born to mothers taking sotalol may also experience symptoms of the drug's effects, including a slow heart rate (bradycardia) or low blood sugar (hypoglycemia). If you are pregnant or planning to become pregnant, discuss the potential risks and benefits with your healthcare provider.

Breastfeeding

Sotalol is excreted into human breast milk. Because the drug can cause serious adverse reactions in nursing infants, such as a slow heart rate, a decision must be made whether to stop breastfeeding or stop taking the medication. This decision should be made in consultation with a healthcare provider, taking into account the importance of the drug to the mother's health.

Question 10

What forms and strengths does Sotalol come in?

Accepted Answer

Sotalol is provided in the following formats:

Oral Tablets: Solid tablets taken by mouth.

Oral Solution: A liquid form of the medication for oral intake.

Intravenous Injection: A solution administered directly into a vein by a medical professional.

Question 11

What is the FDA approval status of Sotalol?

Accepted Answer

FDA Approval and Indications

Sotalol is approved by the U.S. Food and Drug Administration (FDA) for the treatment of documented life-threatening ventricular arrhythmias, such as sustained ventricular tachycardia. It is also indicated for maintaining normal sinus rhythm in patients with highly symptomatic atrial fibrillation or atrial flutter who are currently in sinus rhythm. It is available in oral tablet, oral solution, and intravenous injection forms.

Boxed Warning and Monitoring Requirements

The FDA requires a boxed warning for sotalol due to the risk of proarrhythmia. The medication can cause serious, life-threatening heart rhythm problems, specifically Torsade de Pointes. Because of this risk, the following regulatory requirements are in place:

Initiation of sotalol and any significant increase in dosage must occur in a hospital setting that provides continuous electrocardiogram (ECG) monitoring.

Patients must be monitored for a minimum of three days while on their maintenance dose.

Facilities where sotalol is initiated must have personnel trained in cardiac resuscitation and equipment for managing serious arrhythmias.

Healthcare providers must calculate the patient's creatinine clearance to assess kidney function before administration, as the drug is cleared by the kidneys and requires specific dose adjustments based on renal health.

The QT interval must be monitored closely to prevent excessive prolongation, which increases the risk of dangerous arrhythmias.

Regulatory History

Sotalol was first approved by the FDA in 1992. While it is available as a generic medication, it remains strictly regulated regarding its administration protocol to ensure patient safety. Different formulations of sotalol (such as sotalol hydrochloride and sotalol AF) have specific labeling and indications that are not always interchangeable.

Question 12

What should I know about Sotalol and fda?

Accepted Answer

FDA Indications

Sotalol is approved by the U.S. Food and Drug Administration (FDA) for the following clinical uses:

Ventricular Arrhythmias: Treatment of documented life-threatening ventricular arrhythmias, such as sustained ventricular tachycardia.

Atrial Fibrillation and Flutter: Maintenance of normal sinus rhythm in patients with highly symptomatic atrial fibrillation or atrial flutter who are currently in sinus rhythm.

FDA Boxed Warning

The FDA has issued a boxed warning for sotalol due to the risk of inducing serious ventricular arrhythmias, specifically Torsade de Pointes. To minimize this risk, the FDA requires the following safety protocols:

Patients must be initiated or re-initiated on the medication in a facility that can provide continuous electrocardiogram (ECG) monitoring and cardiac resuscitation.

Patients must be monitored in this setting for at least three days on the maintenance dosage.

Healthcare providers must calculate creatinine clearance to assess kidney function prior to the first dose, as the drug is cleared by the kidneys and requires dosage adjustments.

Approval History and Formulations

The FDA first approved sotalol in oral tablet form in 1992. In 1999, a specific brand (Betapace AF) was approved specifically for the treatment of atrial fibrillation and flutter to ensure distinct labeling for different indications. An intravenous (IV) injection was approved in 2009 for use in patients who are unable to take the medication orally.

Sotalol

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Brand Names

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Fda Information

FAQ

Found an Error?